RMG completes $64m. Israel-based biopharma investment fund
There are currently more than 1,200 companies in the Israeli healthcare market, including 200 in the field of pharma, according to data supplied by Start-Up Nation Central.
RM Global partner Yaron Breski (L) and RM Global (Israel Office) managing director Assaf Keret(photo credit: ADI COHEN ZEDEK)ByEYTAN HALON
